P
PROTON INTELLIGENCE — TRANSFORMING HYPERKALEMIA MANAGEMENT
At Proton Intelligence, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease ;We collect personal information that you voluntarily provide to us when you express an interest in obtaining information about us or our products and Services.;The Magic Word Is Empowerment: A Conversation with Dr. Mandeep Sahani on Action Potential.;The lack of innovation in CKD management and monitoring starkly contrasts the evolution witnessed in diabetes care.;In this inspiring episode of Action Potential, Dr. Mandeep Sahani reminds us that at the heart of effective kidney care lies the power of patient empowerment.;
Company Email ：info@protonintel.com
Industry ：Renewable EnergyHome Appliances
Company website ：*****
Established ：-
Main Products ：--
Web Summary
Q1: What is the company name and its tagline?
A1: The company name is Proton Intelligence, and its tagline is "Transforming Hyperkalemia Management".
Q2: What is the industry of Proton Intelligence?
A2: Proton Intelligence operates in the medical device sector, specifically focusing on hyperkalemia management.
Q3: What is the main product or service offered by Proton Intelligence?
A3: Although the text does not explicitly mention a specific product, it highlights the company's focus on transforming hyperkalemia management, suggesting that they may offer diagnostic tools, monitoring systems, or treatment solutions for this condition.
Q4: What is the target audience for Proton Intelligence's products or services?
A4: The target audience appears to be healthcare professionals, patients with chronic kidney disease (CKD), and caregivers, as the company aims to provide innovative solutions for managing hyperkalemia, a common comorbidity in CKD patients.
Q5: What is the current state of innovation in Chronic Kidney Disease (CKD) management?
A5: The existing tools for diabetes management have been around for decades, providing a robust framework for continuous monitoring and real-time data utilization. In contrast, CKD patients and care teams are still heavily reliant on in-lab visits for monitoring and treatment, contributing to higher costs and potentially poorer outcomes.
Q6: What is the estimated annual healthcare cost per patient with CKD?
A6: According to the text, the annual healthcare cost per patient with CKD can range from $26,000 to nearly $100,000, depending on the severity of the condition and the presence of hyperkalemia.
Q7: How does Proton Intelligence aim to address the gap in tool availability for CKD monitoring and management?
A7: The company aims to channel similar endeavors as those that led to the evolution of Continuous Glucose Monitoring (CGM) technology in diabetes care, with the goal of developing innovative solutions that could propel CKD management into a new epoch of patient-centric care and cost-efficiency.
Q8: What is the significance of empowerment in managing kidney disease, according to Dr. Mandeep Sahani?
A8: According to Dr. Mandeep Sahani, empowerment is a crucial aspect of managing kidney disease, as it enables patients to take an active role in their care, make informed decisions about their treatment, and improve their overall quality of life.
Q9: What is the name of the podcast episode featuring Dr. Mandeep Sahani?
A9: The podcast episode featuring Dr. Mandeep Sahani is titled "The Magic Word Is Empowerment: A Conversation with Dr. Mandeep Sahani on Action Potential".
Q10: What is the organization that published a report on the economic costs of diabetes in the US in 2017?
A10: The American Diabetes Association (ADA) published a report on the economic costs of diabetes in the US in 2017, titled "Economic Costs of Diabetes in the U.S. in 2017".
A1: The company name is Proton Intelligence, and its tagline is "Transforming Hyperkalemia Management".
Q2: What is the industry of Proton Intelligence?
A2: Proton Intelligence operates in the medical device sector, specifically focusing on hyperkalemia management.
Q3: What is the main product or service offered by Proton Intelligence?
A3: Although the text does not explicitly mention a specific product, it highlights the company's focus on transforming hyperkalemia management, suggesting that they may offer diagnostic tools, monitoring systems, or treatment solutions for this condition.
Q4: What is the target audience for Proton Intelligence's products or services?
A4: The target audience appears to be healthcare professionals, patients with chronic kidney disease (CKD), and caregivers, as the company aims to provide innovative solutions for managing hyperkalemia, a common comorbidity in CKD patients.
Q5: What is the current state of innovation in Chronic Kidney Disease (CKD) management?
A5: The existing tools for diabetes management have been around for decades, providing a robust framework for continuous monitoring and real-time data utilization. In contrast, CKD patients and care teams are still heavily reliant on in-lab visits for monitoring and treatment, contributing to higher costs and potentially poorer outcomes.
Q6: What is the estimated annual healthcare cost per patient with CKD?
A6: According to the text, the annual healthcare cost per patient with CKD can range from $26,000 to nearly $100,000, depending on the severity of the condition and the presence of hyperkalemia.
Q7: How does Proton Intelligence aim to address the gap in tool availability for CKD monitoring and management?
A7: The company aims to channel similar endeavors as those that led to the evolution of Continuous Glucose Monitoring (CGM) technology in diabetes care, with the goal of developing innovative solutions that could propel CKD management into a new epoch of patient-centric care and cost-efficiency.
Q8: What is the significance of empowerment in managing kidney disease, according to Dr. Mandeep Sahani?
A8: According to Dr. Mandeep Sahani, empowerment is a crucial aspect of managing kidney disease, as it enables patients to take an active role in their care, make informed decisions about their treatment, and improve their overall quality of life.
Q9: What is the name of the podcast episode featuring Dr. Mandeep Sahani?
A9: The podcast episode featuring Dr. Mandeep Sahani is titled "The Magic Word Is Empowerment: A Conversation with Dr. Mandeep Sahani on Action Potential".
Q10: What is the organization that published a report on the economic costs of diabetes in the US in 2017?
A10: The American Diabetes Association (ADA) published a report on the economic costs of diabetes in the US in 2017, titled "Economic Costs of Diabetes in the U.S. in 2017".
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
